Although the final amount of different subtypes of lymphocytes varied slightly, all the BCG substrains tested gave rise to the upregulation of CD56 on NK cells (Figure 3A, right panel) and increased degranulation against bladder cancer cells (Figure 3B). This evidence concerns the gene NCAM1 and urinary bladder carcinoma.